1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsAccelerating Innovations into CarE (AICE) – Market Access Program is sponsored by Alberta Innovates. This program supports Alberta-based health and life sciences small to medium-sized enterprises (SMEs) in generating scientific and clinical evidence needed for commercialization.
Get alerted about grants like this
Save a search for “Alberta Innovates” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Accelerating Innovations into CarE (AICE) - Alberta Innovates Accelerating Innovations into CarE (AICE) The Accelerating Innovations in CarE (AICE) program offers staged funding streams and support to Alberta’s small- and medium-sized enterprises (SMEs) that require robust scientific and clinical evidence to develop, advance and commercialize cutting edge new health technologies.
Program Status refers to the state of work going on within this particular program. If the Program is 'Active', it is either accepting new applications or research is currently underway. If the Program is 'Inactive', the Program is neither accepting new applications nor is any research being conducted.
Intake Status refers to the state of the Program's call for new applications. If the Intake is displaying 'Open', the Program is accepting new applications. If the Intake is displaying 'Closed', the Program is not accepting new applications.
AICE is a competition-based funding program that provides support to validate and advance product-market fit, business readiness, regulatory compliance, and technical development. Small to Medium Enterprise The AICE program supports Alberta health technology ventures to grow and generate the evidence needed along their journey to achieve validation, market access, and start scaling.
The objectives are to mitigate the risks faced by innovative Alberta health technology SMEs that require preclinical and clinical evidence to get to market by providing non-dilutive funding and access to advice and partners along the way.
AICE offers two funding streams, Validate, and Market Access, based-upon the proposed project activities and the stage of readiness of the technology, the product-market fit, the business, and regulatory compliance: Each stage is outlined further with details of specific activities and milestones to be achieved for each domain in the Health Innovation Roadmap document.
Click the graphic below to access the document: The roadmap is a guide to assess your stage of readiness and alignment to the program streams. Applicants will work closely with Alberta Innovates to determine which funding stream is most appropriate during the application process.
Funding Available: up to 75% of total eligible Project Costs depending on stream: Funding limit from Alberta Innovates: What the funding stream supports: Technology refinement and early validation of technology safety, efficacy and value proposition. Later stage efficacy validation and post-market studies to achieve market access and adoption in various jurisdictions.
Stage required before applying: Readiness level 4 in all domains completed Readiness level 6 in all domains completed *to apply for more than $300,000 under the AICE Market Access program stream see the Program Guide for details. A minimum of 25 per cent of total eligible Project Costs must be provided by the Applicant as cash or in-kind contributions.
The success of this program will be measured in aggregate across the portfolio of projects. While individual project outcomes are expected, all projects should align with the Program Objectives and contribute to the Indicators of Success outlined below: Generate economic benefits to the province by commercializing Alberta- health technologies that will make a positive health impact, both locally and globally.
Increase the number of Alberta health technologies that commercially advance, achieve regulatory compliance, enter the market and are available to patients and care providers; and Attract private investment, generate revenue growth, and create high quality jobs within Alberta’s health and life sciences industry. (%) projects progressing along client journey. (#) products achieving regulatory approvals ($) investment attraction.
The AICE program is open to: Alberta-based for-profit Small-medium sized Enterprises (SMEs) with an Alberta footprint, which is determined by the following: Significant physical and corporate operational presence in Alberta. Appropriate Alberta ownership.
Discernable intent that operational benefits will flow primarily within the province of Alberta; with projects that include: Innovative technologies with potential to directly improve health outcomes and require significant preclinical, safety or clinical efficacy evidence generation to ultimately achieve regulatory approval, reimbursement and/or market adoption Generally NOT a good fit: business management and operational clinic or hospital backend software, natural health products, and unregulated products, such as digital health information apps, virtual communication platforms, direct to consumer goods, wellness products, etc..
Consult the Program Guide for further eligibility criteria and our website for other programs you may be eligible for. Self Assess Fit – Review the Program Guide (posted above) and Support Resources below to confirm fit to all eligibility requirements and program objectives. Intake Form – Complete the “AICE Intake Form” via SmartSimple, our online application portal.
Applicants are strongly encouraged to submit an Intake Form as early as possible, and no later than 6 weeks before a Full Application submission deadline. Intake Meeting – Wait for us to schedule an intake meeting with you to ensure program fit and provide support. Applicants who demonstrate appropriate readiness and meet basic eligibility requirements will be invited to apply.
Full Application – Complete the Full Application via our online application portal. Full Applications are reviewed in multiple cohorts throughout the year. Upcoming application dates are noted below.
If you have any questions about the application process, feel free to contact Alberta Innovates at any time.
Applicants must submit Intake Forms at least 6 weeks in advance of the posted application deadline to be considered, and must submit their Full Applications by 4:00 pm Mountain time on the following submission dates: July 18, 2025 (Intake deadline: June 6, 2025) October 17, 2025 (Intake deadline September 5, 2025) January 16, 2026 (Intake deadline December 5, 2025) Applications are reviewed by Alberta Innovates employees and external expert reviewers.
We evaluate submitted applications to the AICE program based on the technology, business opportunity, risk profile and potential size of the return to Alberta. Consult the Program Guide for full evaluation details. Additional Alberta Innovates Supports and Resources Health Tech Commercialization Supports – Alberta Innovates partners with a variety of other organizations in the ecosystem to provide support for Health Innovators.
View the Health Tech Commercialization Supports page here Entrepreneurial Investments – Alberta Innovates offers a variety of related, high demand entrepreneurial investment programs that are of interest to SMEs. View the Entrepreneurial Investments page here .
Technology Development Advisors – provide front-line business coaching and technology development advice to small and medium-size enterprises in technology or knowledge-based industries. View the Technology Development Advisors page here .
Regional Innovation Networks – Entrepreneur-centric, community-based networks with the goal of providing programs and services to accelerate growth of technology and knowledge-based businesses in Alberta jurisdictions. View the Regional Innovation Networks page here .
SmartSimple Online Application Portal AICE – Eligible and Ineligible Costs AICE Sample Application Form Standard Investment Agreement Template Financial Documents Resource – AICE Senior Business Partner, Research - Health Innovation Markian. Bahniuk@albertainnovates.
ca Open and Upcoming Intakes The AICE program supports the advancement of innovative Alberta health ventures along their journey to generate the evidence needed to achieve proof of concept, validation and market access.
AICE Market Access - Funded Projects Jan 1, 2021 – March 31, 2028 AICE Concepts - 2025 Recipients September 2024 - February 2028 AICE Concepts - 2024 Recipients February 2024 - January 2027 AICE Concepts - 2022 Recipients February 2022 to January 2025 AICE Validate - Funded Projects Jan 1, 2021 – March 31, 2028 AICE Concepts - 2023 Recipients February 2023 to January 2026 Accelerating Innovations into CarE (AICE) - Tech for Healthy Aging Related Strategic Initiatives Sectors: Health & Life Sciences We are advancing digital health technologies to accelerate improvements in the quality and long-term sustainability of our health system and the health of Albertans.
Based on current listing details, eligibility includes: Alberta-based health and life sciences SMEs developing medical devices, digital health solutions, diagnostics, and other biotech innovations that require rigorous evidence before scaling. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Up to $600,000 Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.